NCT07751484

Brief Summary

The goal of this study is to collect OCT scans on normal healthy eyes from an investigational OCT device the VG200D from Intalight, Inc, in order to establish a reference database. The reference database will be used to establish normal ranges for thickness measurement parameters provided by the VG200D OCT software including anterior segment and posterior segment measurements. The study will enroll normal eyes from three clinics in the US including a wide range of ages and races/ethnicities.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
350

participants targeted

Target at P75+ for all trials

Timeline
1mo left

Started Jul 2026

Shorter than P25 for all trials

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress51%
Jul 2026Sep 2026

Study Start

First participant enrolled

July 8, 2026

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

August 3, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 7, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2026

Last Updated

August 7, 2026

Status Verified

August 1, 2026

Enrollment Period

2 months

First QC Date

August 3, 2026

Last Update Submit

August 3, 2026

Conditions

Keywords

Optical Coherence Tomography

Outcome Measures

Primary Outcomes (1)

  • Quantitative ocular structures

    Retinal structural measurements of the anterior and posterior segments of the eye

    this study will alst approximately 6 months

Study Arms (1)

Normal

This group includes subjects with normal healthy eyes as confirmed by a clinical examination by trained eye-care professionals

Device: OCT device called VG200D

Interventions

This is an investigational imaging device

Normal

Eligibility Criteria

Age22 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

A total of approximately 350 subjects without ocular pathology will be enrolled in this study from 3 clinical sites. Subjects will include a diverse range of races and ethnicities and should reflect or generally approximate the general population of the US. The average age of all subjects will be approximately 55-60 years of age or older. The age distribution will be similar to the table below. Percent 5 10 20 25 25 15 Total # 18 35 70 87 88 52 Age 22-30 31-40 41-50 51-60 61-70 71+ Table1. The age distribution of the study participants along with the percentage for each age group and the total number of subjects for each age group to be enrolled. The following seven categories on race and ethnicity were identified and defined and will be used in this study\*: * American Indian or Alaska Native * Asian * Black or African American * Hispanic or Latino * Middle Eastern or North African * Native Hawaiian or Pacific Islander * White

You may qualify if:

  • \. Subject 22 years of age or older on the date of informed consent 2. Subject able to understand the written informed consent and willing to participate as evidenced by signing the informed consent 3. Subjects presenting at the site with normal eyes. Cataracts, LASIK, PRK, and peripheral pathology that does not affect the posterior pole region, for example lattice and peripheral drusen, are allowed.
  • \. BCVA 20/40 or better (each eye) 5. Subject is able to comply with the study procedures

You may not qualify if:

  • \. Subject unable to tolerate ophthalmic imaging 2. Subject has an ocular pathology other than cataract or mild peripheral, age-related changes (e.g., peripheral drusen, lattice, etc.) 3. Glaucoma diagnosis in either eye. 4. Subject has a condition or is in a situation which the investigator feels may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study 5. Subject with ocular media not sufficiently clear to obtain acceptable OCT images

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

New View Optometry

San Diego, California, 91942, United States

RECRUITING

Illinois College of Optometry

Chicago, Illinois, 60616, United States

RECRUITING

Indiana University - School of Optometry

Bloomington, Indiana, 47405, United States

RECRUITING

Central Study Contacts

Mike Sinai, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 3, 2026

First Posted

August 7, 2026

Study Start

July 8, 2026

Primary Completion (Estimated)

September 15, 2026

Study Completion (Estimated)

September 15, 2026

Last Updated

August 7, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

All data will be kept confidential to the site and the Sponsor

Locations